Profile data is unavailable for this security.
About the company
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics technology company. The Company is focused on patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux or simply reflux, that leads to esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma (EAC). The Company’s products include EsoGuard, and EsoCheck. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells in office procedures. It consists of a vitamin pill-sized rigid plastic capsule tethered to a thin silicone catheter from which a soft silicone balloon with textured ridges emerges to swab surface esophageal cells. It is also developing EsoCure, is an Esophageal Ablation Device that allows a clinician to treat dysplastic BE before it can progress to EAC.
- Revenue in USD (TTM)2.98m
- Net income in USD-54.53m
- Incorporated2018
- Employees70.00
- LocationLucid Diagnostics Inc360 Madison Avenue, 25Th FloorNEW YORK 10017United StatesUSA
- Phone+1 (212) 949-4319
- Fax+1 (302) 655-5049
- Websitehttps://www.luciddx.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| electroCore, Inc. | 18.69m | -16.47m | 39.40m | 68.00 | -- | 8.76 | -- | 2.11 | -2.85 | -2.85 | 3.13 | 0.7486 | 1.16 | 1.30 | 54.34 | 274,897.10 | -102.35 | -70.73 | -177.94 | -88.96 | 82.70 | 75.81 | -88.12 | -352.82 | 1.18 | -- | 0.00 | -- | 86.57 | 74.42 | 15.02 | -- | -5.88 | -- |
| Precision Optics Corporation Inc | 19.41m | -1.64m | 39.69m | 84.00 | -- | 3.52 | -- | 2.04 | -0.2706 | -0.2706 | 3.24 | 1.86 | 1.06 | 4.30 | 4.51 | 231,098.50 | -8.98 | -6.71 | -13.18 | -10.55 | 33.65 | 33.65 | -8.43 | -5.02 | 1.05 | -8.86 | 0.1982 | -- | 34.23 | 39.12 | 84.42 | -- | 19.39 | -- |
| Autonomix Medical Inc | 0.00 | -10.68m | 39.84m | 3.00 | -- | -- | -- | -- | -0.5055 | -0.5055 | 0.00 | -0.2649 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 84.50 | -- | -- | -- |
| iCAD Inc | 17.94m | -5.14m | 39.94m | 67.00 | -- | 1.22 | -- | 2.23 | -0.1982 | -0.0894 | 0.6915 | 1.23 | 0.4081 | 0.9199 | 2.47 | 267,731.30 | -11.70 | -23.94 | -14.93 | -34.14 | 85.60 | 76.96 | -28.66 | -45.02 | 4.59 | -- | 0.00 | -- | -12.54 | -7.53 | 29.32 | -- | 23.88 | -- |
| Inspira Technologies Oxy BHN Ltd | 0.00 | -11.29m | 40.12m | 37.00 | -- | 6.33 | -- | -- | -0.9549 | -0.9549 | 0.00 | 0.3666 | 0.00 | -- | -- | 0.00 | -88.60 | -114.98 | -108.36 | -159.56 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 24.64 | -- | -- | -- |
| IRIDEX Corp | 49.92m | -10.94m | 40.14m | 111.00 | -- | 6.19 | -- | 0.8041 | -0.6759 | -0.6759 | 3.08 | 0.3992 | 1.33 | 2.66 | 7.42 | 449,765.80 | -29.16 | -19.54 | -47.74 | -27.46 | 40.72 | 42.67 | -21.92 | -15.45 | 1.03 | -- | 0.00 | -- | -8.96 | 4.02 | -26.81 | -- | -24.35 | -- |
| Cutera Inc | 196.64m | -157.56m | 41.75m | 430.00 | -- | -- | -- | 0.2123 | -7.89 | -7.89 | 9.86 | -9.60 | 0.4864 | 2.29 | 4.43 | 457,293.00 | -38.97 | -22.00 | -50.24 | -30.72 | 16.42 | 47.63 | -80.13 | -27.24 | 2.22 | -43.94 | 1.84 | -- | -15.86 | 5.47 | -97.76 | -- | 85.87 | -- |
| DarioHealth Corp | 19.04m | -59.90m | 43.69m | 276.00 | -- | 0.5508 | -- | 2.29 | -2.04 | -2.04 | 0.633 | 2.65 | 0.1555 | 2.34 | 3.57 | 69,000.00 | -43.90 | -73.26 | -51.33 | -87.59 | 27.56 | 29.54 | -282.38 | -293.54 | 2.67 | -- | 0.2673 | -- | -26.41 | 22.45 | 0.5091 | -- | 52.42 | -- |
| United Health Products Inc | 0.00 | -1.93m | 44.63m | 6.00 | -- | -- | -- | -- | -0.008 | -0.008 | 0.00 | -0.0073 | 0.00 | 0.00 | -- | 0.00 | -719.43 | -6,446.86 | -- | -- | -- | 53.19 | -- | -132,561.20 | 0.0483 | -15.60 | -- | -- | -100.00 | -- | -55.45 | -- | -- | -- |
| Vaso Corp | 80.54m | 3.18m | 46.44m | 300.00 | 12.80 | 1.82 | 11.36 | 0.5766 | 0.0207 | 0.0207 | 0.4589 | 0.1459 | 1.16 | 20.03 | 7.77 | 268,470.00 | 4.57 | 7.60 | 7.44 | 16.62 | 61.83 | 58.39 | 3.95 | 5.82 | 1.37 | -- | 0.0091 | -- | 2.18 | 1.84 | -57.46 | -- | -22.33 | -- |
| Envoy Medical Inc | 297.00k | -22.43m | 47.14m | 34.00 | -- | -- | -- | 158.71 | -2.21 | -2.21 | 0.0194 | -0.3782 | 0.0494 | 0.4737 | 2.36 | 8,735.29 | -381.38 | -- | -2,885.46 | -- | -118.18 | -- | -7,718.86 | -- | 0.8969 | -16.54 | -- | -- | 33.33 | -- | -87.83 | -- | -- | -- |
| Lucid Diagnostics Inc | 2.98m | -54.53m | 47.26m | 70.00 | -- | -- | -- | 15.84 | -1.27 | -1.27 | 0.0698 | 0.2544 | 0.0735 | -- | 78.50 | 42,614.29 | -115.88 | -- | -248.82 | -- | -111.06 | -- | -1,576.63 | -- | 1.36 | -- | 0.5579 | -- | 544.03 | -- | 6.24 | -- | -- | -- |
| Cytosorbents Corp | 36.69m | -27.54m | 47.79m | 186.00 | -- | 2.52 | -- | 1.30 | -0.5869 | -0.5869 | 0.7748 | 0.3486 | 0.7019 | 4.82 | 5.97 | 197,237.50 | -52.69 | -36.00 | -68.27 | -43.52 | 64.08 | 68.15 | -75.07 | -62.71 | 1.21 | -114.70 | 0.1896 | -- | 4.79 | 10.06 | 13.12 | -- | -9.24 | -- |
| LENSAR Inc | 44.50m | -12.27m | 49.46m | 130.00 | -- | 1.55 | -- | 1.11 | -1.13 | -1.13 | 3.92 | 4.00 | 0.7536 | 1.32 | 9.79 | 342,307.70 | -20.78 | -30.97 | -25.12 | -36.94 | 50.45 | 51.04 | -27.57 | -52.30 | 2.36 | -- | 0.00 | -- | 19.25 | 11.57 | 27.77 | -- | -42.91 | -- |
| Icecure Medical Ltd | 3.26m | -14.49m | 50.82m | 71.00 | -- | 4.37 | -- | 15.58 | -0.3157 | -0.3157 | 0.071 | 0.2427 | 0.152 | 0.799 | 21.75 | 45,943.66 | -67.52 | -54.89 | -84.42 | -68.66 | 38.29 | 49.87 | -444.30 | -313.19 | 2.88 | -- | 0.00 | -- | 4.67 | 23.50 | 13.70 | -- | 48.10 | -- |
| Nutriband Inc | 2.09m | -5.49m | 55.40m | 13.00 | -- | 6.95 | -- | 26.57 | -0.6863 | -0.6863 | 0.2622 | 0.7267 | 0.2457 | 6.15 | 15.94 | -- | -64.63 | -55.21 | -72.05 | -66.74 | 41.34 | 33.32 | -263.05 | -315.87 | 0.854 | -82.63 | 0.0312 | -- | 0.2741 | 53.43 | -22.35 | -- | 65.57 | -- |
Data as of May 31 2024. Currency figures normalised to Lucid Diagnostics Inc's reporting currency: US Dollar USD
4.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Luminus Management LLCas of 31 Mar 2024 | 717.66k | 1.49% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 560.92k | 1.16% |
| Geode Capital Management LLCas of 31 Mar 2024 | 155.76k | 0.32% |
| Nantahala Capital Management LLCas of 31 Mar 2024 | 149.70k | 0.31% |
| Jane Street Capital LLCas of 31 Mar 2024 | 122.01k | 0.25% |
| HRT Financial LLCas of 31 Mar 2024 | 63.04k | 0.13% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 50.07k | 0.10% |
| Verition Fund Management LLCas of 31 Mar 2024 | 42.38k | 0.09% |
| LPL Financial LLCas of 31 Mar 2024 | 37.03k | 0.08% |
| Virtu Americas LLCas of 31 Mar 2024 | 34.67k | 0.07% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
